Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaQ

Full company profile

uuid0053muh

Namestring
PharmaQ
Legal namestring
PharmaQ A.E.
Websiteurl
pharmaq.gr
Company typeenum
Private
Founded yearint
2008
Descriptiontext

PharmaQ A.E. is a privately held Greek pharmaceutical company (Société Anonyme) founded in 2008 in Athens and headquartered in Koropi, Attica. Since 2010 it has operated as a member of the IASIS PHARMA group, a Greek pharmaceutical conglomerate. The company markets 27 products across eight therapeutic categories — Allergology, Self-care, Gastroenterology, General Medicine, Dermatology, Pediatric, Oral Hygiene, and Otorhinolaryngology — comprising OTC (non-prescription) pharmaceuticals, medical devices, naturally derived remedies, and self-care products. Distribution is exclusively through pharmacies in Greece and Cyprus, with stated intent to extend into broader European and international markets via partnerships with international pharmaceutical principals.

The portfolio is built around a small number of differentiated formulations: liposomal microencapsulated iron pyrophosphate (Ferrum Iasis), a Melatonin/Valerian/Hops combination sleep product (JustSleep, Gold Award winner at the 2018 Best in Pharmacy Awards), and the EMA-approved Chios Mastiha herbal line (Mastiha var.Chia in capsules, powder sachets, and a regenerative gel). Recent additions include Qpain®, a topical diclofenac cutaneous solution launched in October 2023, and the Chios Mastiha Powder line launched in November 2023. PharmaQ also represents and distributes products from multiple international partners (DMG, Giuliani, Ceutics, Quies, Hartington, Pharmacosmetic-Diafarm, Temmler, Pharmacure) in the Greek market.

The go-to-market is a classic specialty pharma field-sales model: a dedicated sales force targets doctors and pharmacists, supported by active participation in Greek medical congresses (HellasPHARM, PHARMA point, and specialty society meetings across ENT, pediatrics, rhinology, and pediatric nephrology), scientific education, and continuing medical education. Revenue is generated through one-time product sales at the pharmacy counter; no subscription, licensing, or SaaS pricing models are evident. The company is privately held with no disclosed revenue, headcount, or external funding rounds, and operates without any visible AI/ML capability or digital platform layer.

Short descriptiontext

PharmaQ A.E. is a privately held Greek pharmaceutical company (founded 2008, IASIS PHARMA group member) that develops and distributes OTC drugs, medical devices, natural remedies, and self-care products exclusively through pharmacies in Greece and Cyprus, serving doctors, pharmacists, and consumers across eight therapeutic categories.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKoropi, Greece
HQ citystring
Koropi
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
OTC pharmaceuticals, medical devices, natural herbal remedies, self-care products, pharmacy distribution
Industry4 codes
PRIMARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAC
Allergy, Sinus & Respiratory (Non-Asthma)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
OTC Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1OTC Pharmaceuticals
TypeOne Time License
Description

Over-the-counter (OTC) non-prescription drugs (ΜΗ.ΣΥ.ΦΑ.) distributed exclusively through pharmacies

pharmaq.gr
2Medical Devices
TypeOne Time License
Description

Medical devices (Μedical devices) for various therapeutic applications

pharmaq.gr
3Natural Remedies
TypeOne Time License
Description

Naturally derived remedies and natural health products

pharmaq.gr
4Self-care Products
TypeOne Time License
Description

Self-healing/self-care health products for consumer use

pharmaq.gr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1JUSTSLEEP
Description

Sleep aid product combining Melatonin 1mg, Valerian 200mg, and Hops 200mg for natural sleep solutions. Won Gold Award for Innovative New Pharmacy Product at Best in Pharmacy Awards 2018.

pharmaq.gr
+2 more records
Core offering1 text field

PharmaQ develops, markets, and distributes innovative over-the-counter (OTC) pharmaceuticals, medical devices, naturally derived herbal remedies, and self-care products distributed exclusively through pharmacies. The company's portfolio spans 27+ products across eight therapeutic categories including dermatology, gastroenterology, allergology, pediatrics, and otorhinolaryngology, featuring proprietary formulations such as liposomal iron supplements, EMA-approved Chios Mastiha products, and unique combination sleep aids. Products target both the Greek/Cypriot domestic market and broader European/international markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PharmaQ is a Greek pharmaceutical company (S.A.) founded in 2008 in Athens, operating as a member of the IASIS PHARMA group since 2010. The company offers 27 innovative pharmaceutical products and medical devices across 8 therapeutic categories: Allergology (2 products including Flutinasal), Self-care (6 products including Mastiha var.Chia line, Talorbin), Gastroenterology (2 products including Mastiha var.Chia capsules), General medicine (8 products including Ferrum Iasis, JustSleep, Athomer), Dermatology (8 products including Qpain, Sensibio, Acetochlor, Chemiderm, Flusterix), Pediatric (10 products including Stomatovis, Cue, Emofix, Rinopanteina), Oral Hygiene (1 product - Stomatovis), and Otorhinolaryngology (10 products including Nasodren, Nozovent, Quies, Rinopanteina Plus). The product portfolio includes OTC drugs (non-prescription medications), medical devices, naturally-derived remedies, and self-care health products. Key innovative products include Mastiha var.Chia (EMA-approved natural herbal medicine from Chios), Ferrum Iasis (liposomal iron technology), JustSleep (combination sleep aid that won Best in Pharmacy Awards 2018), and Qpain (topical anti-inflammatory with DMSO). All products are exclusively distributed through pharmacies and target both the Greek market and international markets.

Product and service21 records
1Ferrum Iasis
CategoryGeneral Medicine
Description

Enhanced pyrophosphate liposomal iron in microcapsules for iron supplementation. Innovative iron supplement for patients with iron deficiency.

2JustSleep
CategoryGeneral Medicine
Description

Combination of Melatonin 1mg, Valerian 200mg, and Hops 200mg in a single tablet for reducing sleep onset time and providing restful sleep. Won Best in Pharmacy Awards 2018 Gold Award.

3Mastiha var.Chia Caps
CategoryGastroenterology
Description

Natural Chios Mastiha in capsule form, an EMA-approved herbal medicine (since 2015) for digestive health.

4Mastiha var.Chia - Chios Mastiha Powder
CategorySelf-Care
Description

Chios Mastiha in powder form, 1080mg per sachet, package of 15 sachets. A 15-day natural solution for digestive health launched in November 2023.

5Mastiha var.Chia - Cutaneous Regenerative Gel
CategorySelf-Care
Description

Regenerative and soothing gel based on Chios Mastiha for skin application.

6Qpain
CategoryDermatology
Description

Topical anti-inflammatory cutaneous solution containing diclofenac sodium 1.5% w/w with DMSO for enhanced absorption. Indicated for symptomatic relief of pain associated with osteoarthritis in superficial joints including the knee.

7Acetochlor
CategoryDermatology
Description

Monochloroacetic acid solution for dermatological use.

8Athomer - Nasal Spray
CategoryGeneral Medicine
Description

Nasal spray made with Aegean Sea seawater, the only nasal spray with seawater from the Aegean Sea.

9Chemiderm
CategoryDermatology
Description

Dermatological cream product.

10Cue - Otologic Solution
CategoryPediatric
Description

Otologic solution for pediatric use.

11Emofix - Haemostatic Barrier Ointment
CategoryPediatric
Description

Haemostatic barrier ointment for wound care.

12Flusterix
CategoryDermatology
Description

Dermatological product.

13Flutinasal
CategoryAllergology
Description

Nasal spray for seasonal and chronic allergic rhinitis treatment.

14Rinopanteina - Nasal Ointment & Drops
CategoryOtorhinolaryngology
Description

Innovative nasal ointment and drops with D-Panthenol, Vitamin A, oat proteins and mineral oils that lubricate, hydrate and protect the nasal mucosa. Helps re-epithelization and relieves symptoms of allergic, dry and pharmaceutical rhinitis.

15Rinopanteina Plus Nasal Spray
CategoryOtorhinolaryngology
Description

Enhanced nasal spray version of Rinopanteina.

16Stomatovis - Paste & Mouthwash
CategoryOral Hygiene / Pediatric
Description

Stomatovis Paste is the only natural and effective treatment for ulcers from localized aphthae. Innovative composition with Panthenol, Aloe, Vitamins A & E and Zinc Oxide provides immediate pain relief, rapid tissue restoration. Stomatovis Mouthwash treats oral mucosa from stomatitis of various etiology and gingivitis.

17Talorbin
CategorySelf-Care
Description

Granules for oral solution containing Paracetamol 500mg, Ascorbic acid 200mg, and Pheniramine maleate 25mg per sachet.

18Sensibio
CategoryDermatology
Description

Cream for dermatological use containing Fusidic acid 20mg and Betamethasone valerate 1mg per gram. Available in 15g and 30g tubes.

19Nasodren
CategoryOtorhinolaryngology
Description

Product for sinusitis treatment.

20Nozovent
CategoryOtorhinolaryngology
Description

Nasal dilator for respiratory support.

21Quies
CategoryOtorhinolaryngology
Description

Hearing protection and relaxation product.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PharmaQ has been a member of the IASIS PHARMA group since 2010, which is an assertively expanding Greek pharmaceutical association. As part of the group, PharmaQ responds dynamically to new market challenges and benefits from shared resources and strategic direction.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive representation of Chios Mastiha products - EMA approved natural remedy since 2015

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for hearing protection and relaxation products

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

8Pharmacosmetic-Diafarm
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

pharmaq.gr
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical partnership for product distribution

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Greek pharmaceutical company focused on OTC and consumer health products distributed through pharmacies. Highly comparable as a Greek OTC pharma peer of similar scale, category breadth, and exclusive pharmacy-channel strategy.

TypeBroad incumbent
Description

Global consumer healthcare company (spun off from GSK) producing OTC products across pain, respiratory, oral health, and vitamin categories. Comparable as a broad multinational incumbent in the same OTC therapeutic categories PharmaQ serves.

TypeDirect peer
Description

Greek pharmaceutical company producing OTC and prescription products with a focus on innovation and pharmacy distribution. Comparable as a Greek pharma peer emphasizing innovative formulations and pharmacy-channel sales.

TypeBroad incumbent
Description

Global OTC pharmaceutical and consumer healthcare manufacturer producing store-brand and branded OTC products. Comparable as a peer in OTC pharmaceutical manufacturing and category innovation, though operating at much greater scale.

5Bayer Consumer Health
TypeBroad incumbent
Description

Global OTC consumer health division of Bayer covering pain, allergy, cough/cold, and dermatology. Comparable as a multinational incumbent competing in PharmaQ's core OTC categories across European markets.

TypeEmerging player
Description

European specialty pharmaceutical company focused on respiratory, neonatology, and rare disease areas. Comparable as a specialty European pharma with overlapping respiratory focus and similar innovation-driven positioning.

TypeDirect peer
Description

Greek pharmaceutical manufacturer offering branded generics and OTC products through pharmacy channels. Comparable in geography, distribution model, and therapeutic category breadth as a domestic OTC pharma peer.

TypeDirect peer
Description

Greek pharmaceutical manufacturer producing a broad portfolio of pharmaceutical products distributed in domestic and international markets. Comparable in geographic focus, product category diversity, and pharmacy-channel distribution.

TypeBroad incumbent
Description

PharmaQ's parent group and a Greek pharmaceutical conglomerate representing multiple international pharma companies. Directly comparable as the broader group within which PharmaQ operates, providing shared distribution and corporate resources.

TypeRegional player
Description

Producer and retailer of Chios Mastiha-based natural products. Comparable as the source partner for PharmaQ's Mastiha var.Chia line, with overlapping natural-product and Chios Mastiha category exposure across digestive and self-care applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaQ

OTC Pharmaceuticalspharmaq.gr

PharmaQ A.E. is a privately held Greek pharmaceutical company (founded 2008, IASIS PHARMA group member) that develops and distributes OTC drugs, medical devices, natural remedies, and self-care products exclusively through pharmacies in Greece and Cyprus, serving doctors, pharmacists, and consumers across eight therapeutic categories.

What PharmaQ does

PharmaQ A.E. is a privately held Greek pharmaceutical company (Société Anonyme) founded in 2008 in Athens and headquartered in Koropi, Attica. Since 2010 it has operated as a member of the IASIS PHARMA group, a Greek pharmaceutical conglomerate. The company markets 27 products across eight therapeutic categories — Allergology, Self-care, Gastroenterology, General Medicine, Dermatology, Pediatric, Oral Hygiene, and Otorhinolaryngology — comprising OTC (non-prescription) pharmaceuticals, medical devices, naturally derived remedies, and self-care products. Distribution is exclusively through pharmacies in Greece and Cyprus, with stated intent to extend into broader European and international markets via partnerships with international pharmaceutical principals.

The portfolio is built around a small number of differentiated formulations: liposomal microencapsulated iron pyrophosphate (Ferrum Iasis), a Melatonin/Valerian/Hops combination sleep product (JustSleep, Gold Award winner at the 2018 Best in Pharmacy Awards), and the EMA-approved Chios Mastiha herbal line (Mastiha var.Chia in capsules, powder sachets, and a regenerative gel). Recent additions include Qpain®, a topical diclofenac cutaneous solution launched in October 2023, and the Chios Mastiha Powder line launched in November 2023. PharmaQ also represents and distributes products from multiple international partners (DMG, Giuliani, Ceutics, Quies, Hartington, Pharmacosmetic-Diafarm, Temmler, Pharmacure) in the Greek market.

The go-to-market is a classic specialty pharma field-sales model: a dedicated sales force targets doctors and pharmacists, supported by active participation in Greek medical congresses (HellasPHARM, PHARMA point, and specialty society meetings across ENT, pediatrics, rhinology, and pediatric nephrology), scientific education, and continuing medical education. Revenue is generated through one-time product sales at the pharmacy counter; no subscription, licensing, or SaaS pricing models are evident. The company is privately held with no disclosed revenue, headcount, or external funding rounds, and operates without any visible AI/ML capability or digital platform layer.

PharmaQ firmographics

Firmographics
Name
PharmaQ
Legal name
PharmaQ A.E.
Website
https://pharmaq.gr
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
PharmaQ A.E. is a privately held Greek pharmaceutical company (founded 2008, IASIS PHARMA group member) that develops and distributes OTC drugs, medical devices, natural remedies, and self-care products exclusively through pharmacies in Greece and Cyprus, serving doctors, pharmacists, and consumers across eight therapeutic categories.
Ownership category
akta.pro rank

PharmaQ industry classification

Industry
Product category
OTC Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIADAA
Pain Relief & Anti-Inflammatory (Analgesics)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAC
Allergy, Sinus & Respiratory (Non-Asthma)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • OTC pharmaceuticals
  • Medical devices
  • Natural herbal remedies
  • Self-care products
  • Pharmacy distribution

Where PharmaQ is headquartered

Location

Headquarters

HQ city
Koropi
HQ country
Greece
HQ region
Europe

Offices1 record

Markets served

PharmaQ business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. OTC Pharmaceuticals: Over-the-counter (OTC) non-prescription drugs (ΜΗ.ΣΥ.ΦΑ.) distributed exclusively through pharmacies
  2. Medical Devices: Medical devices (Μedical devices) for various therapeutic applications
  3. Natural Remedies: Naturally derived remedies and natural health products
  4. Self-care Products: Self-healing/self-care health products for consumer use

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

PharmaQ product offering

Product offering

Core offering

PharmaQ develops, markets, and distributes innovative over-the-counter (OTC) pharmaceuticals, medical devices, naturally derived herbal remedies, and self-care products distributed exclusively through pharmacies. The company's portfolio spans 27+ products across eight therapeutic categories including dermatology, gastroenterology, allergology, pediatrics, and otorhinolaryngology, featuring proprietary formulations such as liposomal iron supplements, EMA-approved Chios Mastiha products, and unique combination sleep aids. Products target both the Greek/Cypriot domestic market and broader European/international markets.

Product overview

PharmaQ is a Greek pharmaceutical company (S.A.) founded in 2008 in Athens, operating as a member of the IASIS PHARMA group since 2010. The company offers 27 innovative pharmaceutical products and medical devices across 8 therapeutic categories: Allergology (2 products including Flutinasal), Self-care (6 products including Mastiha var.Chia line, Talorbin), Gastroenterology (2 products including Mastiha var.Chia capsules), General medicine (8 products including Ferrum Iasis, JustSleep, Athomer), Dermatology (8 products including Qpain, Sensibio, Acetochlor, Chemiderm, Flusterix), Pediatric (10 products including Stomatovis, Cue, Emofix, Rinopanteina), Oral Hygiene (1 product - Stomatovis), and Otorhinolaryngology (10 products including Nasodren, Nozovent, Quies, Rinopanteina Plus). The product portfolio includes OTC drugs (non-prescription medications), medical devices, naturally-derived remedies, and self-care health products. Key innovative products include Mastiha var.Chia (EMA-approved natural herbal medicine from Chios), Ferrum Iasis (liposomal iron technology), JustSleep (combination sleep aid that won Best in Pharmacy Awards 2018), and Qpain (topical anti-inflammatory with DMSO). All products are exclusively distributed through pharmacies and target both the Greek market and international markets.

Differentiator

Problem solved

Functional benefit

Brands

  • JUSTSLEEP: Sleep aid product combining Melatonin 1mg, Valerian 200mg, and Hops 200mg for natural sleep solutions. Won Gold Award for Innovative New Pharmacy Product at Best in Pharmacy Awards 2018.
  • Ferrum Iasis
  • Mastiha var. Chia

Products and services

  • Ferrum Iasis Enhanced pyrophosphate liposomal iron in microcapsules for iron supplementation. Innovative iron supplement for patients with iron deficiency.
  • JustSleep Combination of Melatonin 1mg, Valerian 200mg, and Hops 200mg in a single tablet for reducing sleep onset time and providing restful sleep. Won Best in Pharmacy Awards 2018 Gold Award.
  • Mastiha var.Chia Caps Natural Chios Mastiha in capsule form, an EMA-approved herbal medicine (since 2015) for digestive health.
  • Mastiha var.Chia - Chios Mastiha Powder Chios Mastiha in powder form, 1080mg per sachet, package of 15 sachets. A 15-day natural solution for digestive health launched in November 2023.
  • Mastiha var.Chia - Cutaneous Regenerative Gel Regenerative and soothing gel based on Chios Mastiha for skin application.
  • Qpain Topical anti-inflammatory cutaneous solution containing diclofenac sodium 1.5% w/w with DMSO for enhanced absorption. Indicated for symptomatic relief of pain associated with osteoarthritis in superficial joints including the knee.
  • Acetochlor Monochloroacetic acid solution for dermatological use.
  • Athomer - Nasal Spray Nasal spray made with Aegean Sea seawater, the only nasal spray with seawater from the Aegean Sea.
  • Chemiderm Dermatological cream product.
  • Cue - Otologic Solution Otologic solution for pediatric use.
  • Emofix - Haemostatic Barrier Ointment Haemostatic barrier ointment for wound care.
  • Flusterix Dermatological product.
  • Flutinasal Nasal spray for seasonal and chronic allergic rhinitis treatment.
  • Rinopanteina - Nasal Ointment & Drops Innovative nasal ointment and drops with D-Panthenol, Vitamin A, oat proteins and mineral oils that lubricate, hydrate and protect the nasal mucosa. Helps re-epithelization and relieves symptoms of allergic, dry and pharmaceutical rhinitis.
  • Rinopanteina Plus Nasal Spray Enhanced nasal spray version of Rinopanteina.
  • Stomatovis - Paste & Mouthwash Stomatovis Paste is the only natural and effective treatment for ulcers from localized aphthae. Innovative composition with Panthenol, Aloe, Vitamins A & E and Zinc Oxide provides immediate pain relief, rapid tissue restoration. Stomatovis Mouthwash treats oral mucosa from stomatitis of various etiology and gingivitis.
  • Talorbin Granules for oral solution containing Paracetamol 500mg, Ascorbic acid 200mg, and Pheniramine maleate 25mg per sachet.
  • Sensibio Cream for dermatological use containing Fusidic acid 20mg and Betamethasone valerate 1mg per gram. Available in 15g and 30g tubes.
  • Nasodren Product for sinusitis treatment.
  • Nozovent Nasal dilator for respiratory support.
  • Quies Hearing protection and relaxation product.

Companies that use PharmaQ

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

PharmaQ technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

PharmaQ partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • IASIS PHARMAcoreStrategic or Co-development PartnerPharmaQ has been a member of the IASIS PHARMA group since 2010, which is an assertively expanding Greek pharmaceutical association. As part of the group, PharmaQ responds dynamically to new market challenges and benefits from shared resources and strategic direction.
  • Mastiha Producers (Chios)coreChannel Partner/ Reseller/ DistributorExclusive representation of Chios Mastiha products - EMA approved natural remedy since 2015
  • DMGminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • GiulianiminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • CeuticsminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • QuiesminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for hearing protection and relaxation products
  • HartingtonminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • Pharmacosmetic-DiafarmminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • TemmlerminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution
  • PharmacureminorChannel Partner/ Reseller/ DistributorInternational pharmaceutical partnership for product distribution

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

PharmaQ competitors and assessment

Company assessment

Direct peers

  • Help Pharmaceuticals: Greek pharmaceutical company focused on OTC and consumer health products distributed through pharmacies. Highly comparable as a Greek OTC pharma peer of similar scale, category breadth, and exclusive pharmacy-channel strategy.
  • ELPEN Pharmaceutical: Greek pharmaceutical company producing OTC and prescription products with a focus on innovation and pharmacy distribution. Comparable as a Greek pharma peer emphasizing innovative formulations and pharmacy-channel sales.
  • Galenica SA: Greek pharmaceutical manufacturer offering branded generics and OTC products through pharmacy channels. Comparable in geography, distribution model, and therapeutic category breadth as a domestic OTC pharma peer.
  • Demo SA: Greek pharmaceutical manufacturer producing a broad portfolio of pharmaceutical products distributed in domestic and international markets. Comparable in geographic focus, product category diversity, and pharmacy-channel distribution.

Broad incumbents

  • Haleon: Global consumer healthcare company (spun off from GSK) producing OTC products across pain, respiratory, oral health, and vitamin categories. Comparable as a broad multinational incumbent in the same OTC therapeutic categories PharmaQ serves.
  • Perrigo Company: Global OTC pharmaceutical and consumer healthcare manufacturer producing store-brand and branded OTC products. Comparable as a peer in OTC pharmaceutical manufacturing and category innovation, though operating at much greater scale.
  • Bayer Consumer Health: Global OTC consumer health division of Bayer covering pain, allergy, cough/cold, and dermatology. Comparable as a multinational incumbent competing in PharmaQ's core OTC categories across European markets.
  • IASIS PHARMA: PharmaQ's parent group and a Greek pharmaceutical conglomerate representing multiple international pharma companies. Directly comparable as the broader group within which PharmaQ operates, providing shared distribution and corporate resources.

Emerging players

  • Chiesi Farmaceutici: European specialty pharmaceutical company focused on respiratory, neonatology, and rare disease areas. Comparable as a specialty European pharma with overlapping respiratory focus and similar innovation-driven positioning.

Regional players

  • Mastihashop (Chios Mastiha producers): Producer and retailer of Chios Mastiha-based natural products. Comparable as the source partner for PharmaQ's Mastiha var.Chia line, with overlapping natural-product and Chios Mastiha category exposure across digestive and self-care applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

PharmaQ social profiles

Digital presence

PharmaQ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaQ leadership team

Management profile

Number of profiles

PharmaQ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaQ M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaQ

What does PharmaQ do?

PharmaQ develops, markets, and distributes innovative over-the-counter (OTC) pharmaceuticals, medical devices, naturally derived herbal remedies, and self-care products distributed exclusively through pharmacies. The company's portfolio spans 27+ products across eight therapeutic categories including dermatology, gastroenterology, allergology, pediatrics, and otorhinolaryngology, featuring proprietary formulations such as liposomal iron supplements, EMA-approved Chios Mastiha products, and unique combination sleep aids. Products target both the Greek/Cypriot domestic market and broader European/international markets.

Is PharmaQ a public or private company?

PharmaQ is a private company. It is classified as corporate owned and is currently operating.

When was PharmaQ founded?

PharmaQ was founded in 2008. It employs 11 to 50 people.

Where is PharmaQ based?

PharmaQ is headquartered in Koropi, Greece, in the Europe region.

How does PharmaQ make money?

Four revenue lines are on record. OTC Pharmaceuticals are the primary driver. The others are medical Devices, natural Remedies and self-care Products.

Who are PharmaQ's main competitors?

Direct peers on record are Help Pharmaceuticals, ELPEN Pharmaceutical, Galenica SA and Demo SA. Broad incumbents are Haleon, Perrigo Company, Bayer Consumer Health and IASIS PHARMA. Chiesi Farmaceutici is listed as an emerging player. Mastihashop (Chios Mastiha producers) is listed as a regional player.

Does PharmaQ have an API?

No public API is recorded for PharmaQ.

What industry is PharmaQ in?

PharmaQ's product category is OTC Pharmaceuticals. Its primary akta.pro industry code is HLAIADAA, Pain Relief & Anti-Inflammatory (Analgesics), with a secondary code of HLAIADAC, Allergy, Sinus & Respiratory (Non-Asthma). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales